Bonk, Inc. (NASDAQ: BNKK), formerly known as Safety Shot, Inc., reported significant financial performance improvements in its latest quarterly filing for the three months ended March 31, 2026. The company generated revenues of $4.34 million, a substantial increase from $42,101 in the same period last year. This growth is attributed to the addition of sales from Yerbae Brands Inc. and a revenue-sharing agreement with LetsBonk.fun. The gross profit for the quarter was reported at $3.59 million, compared to $20,989 in the prior year, reflecting a notable shift in the company's revenue-generating capabilities.
Operating expenses for the quarter decreased to $2.22 million from $5.41 million in the previous year, primarily due to reduced legal and professional fees. The net loss for the period was $1.83 million, a significant improvement from the $5.33 million loss reported in the same quarter of 2025. The company’s basic loss per share was $(0.23), compared to $(2.69) in the prior year, indicating a positive trend in financial performance.
Strategically, Bonk, Inc. has undergone several significant developments, including the acquisition of assets from GBB Drink Lab, Inc. in August 2023, which included the Sure Shot Dietary Supplement. The company launched this product in December 2023, aiming to capitalize on the growing market for dietary supplements. Additionally, Bonk has expanded its digital asset strategy, which has contributed to its revenue growth. The company is also focused on enhancing its product offerings, with plans to introduce new flavors and formats for its dietary supplements.
Operationally, Bonk, Inc. has seen an increase in customer engagement, with a reported rise in accounts receivable to $729,925 from $90,140 year-over-year. The company’s digital assets, which include BONK tokens, have also been a focal point, with a fair value of $16.42 million as of March 31, 2026. The company’s workforce remains small, with eight full-time employees, but it is actively seeking to expand its management team to support its growth initiatives.
Looking ahead, Bonk, Inc. faces challenges related to its accumulated deficit of $185.32 million and ongoing cash flow used in operations of $1.94 million for the quarter. The company’s auditors have expressed doubt about its ability to continue as a going concern, emphasizing the need for additional capital to support its expansion plans. Despite these challenges, Bonk remains optimistic about its growth trajectory, driven by its innovative product offerings and strategic partnerships in the dietary supplement and digital asset markets.
About Safety Shot, Inc.
Safety Shot, Inc. develops and commercializes dietary supplements aimed at reducing blood alcohol content. Its flagship product, Sure Shot, contains 28 GRAS ingredients and is marketed through e-commerce and retail stores. The company emphasizes innovation, clinical research, and quality manufacturing, focusing on health and wellness markets. It owns patents related to alcohol metabolism support and collaborates with partners to expand product offerings and distribution channels.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.